LNSRLENSAR, Inc.

$141M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M+57.0% YoY

Gross Profit

$4M56.3% margin

Operating Income

-$4M-55.2% margin

Net Income

-$4M-55.1% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

+12.5%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$72M

Total Liabilities

$11M

Stockholders' Equity

$62M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+57.0%
Gross Profit	$4M	$2M	+129.1%
Operating Income	-$4M	-$4M	-13.8%
Net Income	-$4M	-$4M	+3.0%

Revenue Segments

Product

$6M89%

Service

$726,00011%

Geographic Segments

UNITED STATES

$4M58%

KOREA, REPUBLIC OF

$1M18%

Europe

$921,00014%

Asia Excluding South Korea

$633,0009%

Other Geographical Region

$96,0001%

LNSR Q2 2021 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena